Table 2 SNP array testing for blastocysts
Clinical data | Couples | Total | ||||
|---|---|---|---|---|---|---|
Robertsonian translocation | Reciprocal translocation | Inversion | PGS | Sex chromosome abnormality | ||
No. of cases | 105 | 342 | 14 | 94 | 58 | 613 |
Maternal age (mean ± SD) | 29.7 ± 4.18 | 29.1 ± 4.24 | 30.9 ± 4.08 | 33.9 ± 4.97 | 29.7 ± 4.29 | 29.9 ± 4.68 |
No.of blastocysts biopsied | 457 | 1393 | 82 | 303 | 215 | 2450 |
Euploidy(%) | 257 (56.2%) | 497 (35.7%) | 42 (51.2%) | 188 (62.0%) | 111 (51.6%) | 1095 (44.7%) |
Numerical abnormality (%) | 177 (38.7%) | 289 (20.7%) | 27 (32.9%) | 86 (28.3%) | 75 (34.9%) | 654 (26.7%) |
Structural abnormality (%) | 13 (2.8%) | 338 (24.3%) | 7 (8.5%) | 19 (6.3%) | 16 (7.4%) | 393 (16%) |
Complex abnormalities(%) | 9 (2.0%) | 266 (19.1%) | 5 (6.0%) | 10 (3.3%) | 9 (4.2%) | 299 (12.2%) |
UPD (%) | 1 (0.2%) | 3 (0.2%) | 1 (1.2%) | 0 | 4 (1.9%) | 9 (0.4%) |